RAF1 facilitates KIT signaling and serves as a potential treatment target for gastrointestinal stromal tumor-Reference-Cited by-同舟云学术

RAF1 facilitates KIT signaling and serves as a potential treatment target for gastrointestinal stromal tumor

Published:2024-05-17 Issue:27 Volume:43 Page:2078-2091
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Zhang Liangying,Zhang Shaoting,Cao Xu,Shi Jun,Zhao Sien,Tian Jinhai,Xiao Kun,Wang Ming,Liu Jing,Wang Chengdong,Zhou Liangji,Yu Yuanyuan,Zhao Hui^ORCID,Li Shujing^ORCID,Sun Jianmin^ORCID

Funder

National Natural Science Foundation of China

Natural Science Foundation of Ningxia Province

the General Research Fund of the Research Grants Council of Hong Kong

Publisher

Springer Science and Business Media LLC

Link

https://www.nature.com/articles/s41388-024-03063-8.pdf

Reference53 articles.

1. Soreide K, Sandvik OM, Soreide JA, Giljaca V, Jureckova A, Bulusu VR. Global epidemiology of gastrointestinal stromal tumours (GIST): A systematic review of population-based cohort studies. Cancer Epidemiol. 2016;40:39–46.

2. Nishida T, Yoshinaga S, Takahashi T, Naito Y. Recent Progress and Challenges in the Diagnosis and Treatment of Gastrointestinal Stromal Tumors. Cancers. 2021;13:3158.

3. Patel SR, Reichardt P. An updated review of the treatment landscape for advanced gastrointestinal stromal tumors. Cancer. 2021;127:2187–95.

4. Antonescu CR, Sommer G, Sarran L, Tschernyavsky SJ, Riedel E, Woodruff JM, et al. Association of KIT exon 9 mutations with nongastric primary site and aggressive behavior: KIT mutation analysis and clinical correlates of 120 gastrointestinal stromal tumors. Clinical cancer research : an official journal of the American Association for. Cancer Res. 2003;9:3329–37.

5. Kang HJ, Nam SW, Kim H, Rhee H, Kim NG, Kim H, et al. Correlation of KIT and platelet-derived growth factor receptor alpha mutations with gene activation and expression profiles in gastrointestinal stromal tumors. Oncogene. 2005;24:1066–74.